Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BARRECA, Marilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.464
NA - Nord America 1.438
AS - Asia 1.006
SA - Sud America 265
AF - Africa 37
OC - Oceania 2
Totale 4.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.401
IT - Italia 554
RU - Federazione Russa 382
SG - Singapore 366
CN - Cina 232
BR - Brasile 222
DE - Germania 155
HK - Hong Kong 118
VN - Vietnam 115
PL - Polonia 74
FI - Finlandia 64
FR - Francia 53
GB - Regno Unito 43
JP - Giappone 35
NL - Olanda 33
BD - Bangladesh 23
IN - India 23
AR - Argentina 21
AT - Austria 21
IE - Irlanda 20
KR - Corea 15
CA - Canada 14
MX - Messico 13
IQ - Iraq 12
CH - Svizzera 11
UA - Ucraina 10
UZ - Uzbekistan 10
BE - Belgio 9
SE - Svezia 9
TR - Turchia 9
TW - Taiwan 9
MY - Malesia 8
EG - Egitto 7
ZA - Sudafrica 7
ID - Indonesia 6
RO - Romania 6
KE - Kenya 5
DZ - Algeria 4
EC - Ecuador 4
PK - Pakistan 4
TN - Tunisia 4
UY - Uruguay 4
VE - Venezuela 4
BO - Bolivia 3
CL - Cile 3
CO - Colombia 3
EE - Estonia 3
IR - Iran 3
JM - Giamaica 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
SA - Arabia Saudita 3
BG - Bulgaria 2
CG - Congo 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GH - Ghana 2
IL - Israele 2
MA - Marocco 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ES - Italia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 4.212
Salva come PNG Salva come JPEG
Città #
Singapore 230
Ashburn 222
Palermo 206
San Jose 138
Chandler 99
Hong Kong 89
Zgierz 71
Council Bluffs 66
Fairfield 62
Moscow 59
Helsinki 56
Beijing 53
The Dalles 47
Los Angeles 43
Chicago 35
Hefei 35
Hanoi 34
Milan 33
Lauterbourg 31
Tokyo 30
Ho Chi Minh City 29
Woodbridge 27
Cambridge 26
Dallas 26
Ann Arbor 24
Ludwigshafen am Rhein 24
Santa Clara 24
Houston 21
Medford 20
New York 20
Wilmington 20
Berlin 18
Central 18
São Paulo 18
Dublin 16
Nuremberg 16
Buffalo 15
Frankfurt am Main 15
Rome 15
San Diego 15
Princeton 14
Altamura 13
Lawrence 13
Orem 13
Vienna 13
London 12
Brussels 9
Naples 9
Tampa 9
Columbus 8
Lappeenranta 8
Lercara Friddi 8
Tashkent 8
West Jordan 8
Amsterdam 7
Belo Horizonte 7
Salt Lake City 7
San Paolo di Civitate 7
Seattle 7
Andover 6
Boston 6
Da Nang 6
Des Moines 6
Lugano 6
Padova 6
Paris 6
Partanna 6
Rio de Janeiro 6
Atlanta 5
Bengaluru 5
Cagliari 5
Cairo 5
Campinas 5
Capaci 5
Catanzaro 5
Corigliano Calabro 5
Curitiba 5
Haiphong 5
Hanover 5
Manchester 5
Nairobi 5
Napoli 5
Redondo Beach 5
San Francisco 5
Tianjin 5
Baghdad 4
Buenos Aires 4
Civitanova Marche 4
Fortaleza 4
Guangzhou 4
Hangzhou 4
Kuala Lumpur 4
Mexico City 4
Montreal 4
Porto Alegre 4
Rubano 4
Salvador 4
Shanghai 4
Stockholm 4
Taipei 4
Totale 2.425
Salva come PNG Salva come JPEG
Nome #
Current development of CFTR potentiators in the last decade 265
[1,2]OXAZOLE DERIVATIVES: SYNTHESIS AND BIOLOGICAL EVALUATION AGAINST MULTIPLE MALIGNANT CELL TYPES 217
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 181
Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors 180
GPCR Inhibition in Treating Lymphoma 169
Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells 167
Pyrrolo[2',3':3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types 162
Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis 150
Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes 145
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein 142
Editorial: Emerging heterocycles as bioactive compounds 141
THE KEY ROLE OF THE CLINICAL PHARMACIST IN THE MANAGEMENT OF ANTICANCER THERAPIES: A PILOT STUDY IN THE TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER 137
An overview on anti-tubulin agents for the treatment of lymphoma patients 136
Insight on pyrimido[5,4-g]indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepine systems as promising photosensitizers on malignant cells 136
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis 129
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors 128
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma 127
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel 125
Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis 117
Recurrence of the oxazole motif in tubulin colchicine site inhibitors with anti-tumor activity 114
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 107
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas 106
Secondary resistance to the PI3K inhibitor copanlisib in marginal zone lymphoma 106
Screening of fractions from marine sponges and other invertebrates to identify new lead compounds with anti-tumor activity in lymphoma models 106
Advances in developing noncovalent small molecules targeting Keap1 105
New tricyclic systems as photosensitizers towards triple negative breast cancer cells 103
HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches 101
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences 95
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas 95
In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors 92
Synthesis of 2H-Imidazo[2′,1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutations 85
Modulators of anion channels and transporters as alternative therapeutic agents to normalize airway surface liquid in cystic fibrosis 84
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 83
Microwave‐Enhanced Synthesis of 2‐Styrylquinoline‐4‐Carboxamides With Promising Anti‐Lymphoma Activity 63
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib 58
Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma 52
A Tetrahydro-isoquinoline derivative as a novel mGlu2/3 Ago/PAM with therapeutic potential in models of Parkinsonism 11
Totale 4.520
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 12 33
2021/2022291 29 37 7 6 5 14 16 9 63 33 15 57
2022/2023542 34 60 18 29 64 61 29 43 64 51 72 17
2023/2024346 15 32 14 46 22 29 75 36 10 12 19 36
2024/2025997 47 66 52 75 38 62 162 87 49 98 121 140
2025/20262.149 170 54 204 217 186 339 304 231 213 133 98 0
Totale 4.520